Dapagliflozin-Does Cost Make 4-Pillar Heart Failure Therapy Too Herculean a Labor for Medicine?
JAMA Cardiol
.
2021 Aug 1;6(8):875-876.
doi: 10.1001/jamacardio.2021.1448.
Authors
Derek S Chew
1
,
Daniel B Mark
1
2
Affiliations
1
Duke Clinical Research Institute, Duke University, Durham, North Carolina.
2
Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
PMID:
34037664
DOI:
10.1001/jamacardio.2021.1448
No abstract available
Publication types
Editorial
Comment
MeSH terms
Benzhydryl Compounds / therapeutic use
Glucosides* / therapeutic use
Heart Failure* / drug therapy
Humans
Substances
Benzhydryl Compounds
Glucosides
dapagliflozin